These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27491694)

  • 1. Neuronal cholesterol metabolism increases dendritic outgrowth and synaptic markers via a concerted action of GGTase-I and Trk.
    Moutinho M; Nunes MJ; Correia JC; Gama MJ; Castro-Caldas M; Cedazo-Minguez A; Rodrigues CM; Björkhem I; Ruas JL; Rodrigues E
    Sci Rep; 2016 Aug; 6():30928. PubMed ID: 27491694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol 24S-Hydroxylase Overexpression Inhibits the Liver X Receptor (LXR) Pathway by Activating Small Guanosine Triphosphate-Binding Proteins (sGTPases) in Neuronal Cells.
    Moutinho M; Nunes MJ; Gomes AQ; Gama MJ; Cedazo-Minguez A; Rodrigues CM; Björkhem I; Rodrigues E
    Mol Neurobiol; 2015; 51(3):1489-503. PubMed ID: 25084760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease.
    Djelti F; Braudeau J; Hudry E; Dhenain M; Varin J; Bièche I; Marquer C; Chali F; Ayciriex S; Auzeil N; Alves S; Langui D; Potier MC; Laprevote O; Vidaud M; Duyckaerts C; Miles R; Aubourg P; Cartier N
    Brain; 2015 Aug; 138(Pt 8):2383-98. PubMed ID: 26141492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1).
    Mast N; Lin JB; Anderson KW; Bjorkhem I; Pikuleva IA
    PLoS One; 2017; 12(10):e0187168. PubMed ID: 29073233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.
    Boussicault L; Alves S; Lamazière A; Planques A; Heck N; Moumné L; Despres G; Bolte S; Hu A; Pagès C; Galvan L; Piguet F; Aubourg P; Cartier N; Caboche J; Betuing S
    Brain; 2016 Mar; 139(Pt 3):953-70. PubMed ID: 26912634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatin-modifying agents increase transcription of CYP46A1, a key player in brain cholesterol elimination.
    Milagre I; Nunes MJ; Moutinho M; Rivera I; Fuso A; Scarpa S; Gama MJ; Rodrigues E
    J Alzheimers Dis; 2010; 22(4):1209-21. PubMed ID: 20930312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Type Specific Regulation of Cholesterogenesis by CYP46A1 Re-Expression in zQ175 HD Mouse Striatum.
    Pinchaud K; Masson C; Dayre B; Mounier C; Gilles JF; Vanhoutte P; Caboche J; Betuing S
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol 24-hydroxylase: Brain cholesterol metabolism and beyond.
    Moutinho M; Nunes MJ; Rodrigues E
    Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):1911-1920. PubMed ID: 27663182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin requires geranylgeranyl transferase-I and Rac1 activation to exert neuronal protection and induce plasticity.
    Posada-Duque RA; Velasquez-Carvajal D; Eckert GP; Cardona-Gomez GP
    Neurochem Int; 2013 Mar; 62(4):433-45. PubMed ID: 23411415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of CYP46A1 as a novel therapeutic target for neurological disorders: An updated review of mechanisms.
    Alavi MS; Karimi G; Ghanimi HA; Roohbakhsh A
    Eur J Pharmacol; 2023 Jun; 949():175726. PubMed ID: 37062503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain Acetyl-CoA Production and Phosphorylation of Cytoskeletal Proteins Are Targets of CYP46A1 Activity Modulation and Altered Sterol Flux.
    Mast N; Petrov AM; Prendergast E; Bederman I; Pikuleva IA
    Neurotherapeutics; 2021 Jul; 18(3):2040-2060. PubMed ID: 34235635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo consequences of cholesterol-24S-hydroxylase (CYP46A1) inhibition by voriconazole on cholesterol homeostasis and function in the rat retina.
    Fourgeux C; Martine L; Acar N; Bron AM; Creuzot-Garcher CP; Bretillon L
    Biochem Biophys Res Commun; 2014 Apr; 446(3):775-81. PubMed ID: 24491555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma.
    Han M; Wang S; Yang N; Wang X; Zhao W; Saed HS; Daubon T; Huang B; Chen A; Li G; Miletic H; Thorsen F; Bjerkvig R; Li X; Wang J
    EMBO Mol Med; 2020 Jan; 12(1):e10924. PubMed ID: 31777202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked change in the balance between CYP27A1 and CYP46A1 mediated elimination of cholesterol during differentiation of human neuronal cells.
    Milagre I; Olin M; Nunes MJ; Moutinho M; Lövgren-Sandblom A; Gama MJ; Björkhem I; Rodrigues E
    Neurochem Int; 2012 Jan; 60(2):192-8. PubMed ID: 22185844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases.
    Petrov AM; Pikuleva IA
    Neurotherapeutics; 2019 Jul; 16(3):635-648. PubMed ID: 31001737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol-24S-hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina.
    Bretillon L; Diczfalusy U; Björkhem I; Maire MA; Martine L; Joffre C; Acar N; Bron A; Creuzot-Garcher C
    Curr Eye Res; 2007 Apr; 32(4):361-6. PubMed ID: 17453958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal differentiation alters the ratio of Sp transcription factors recruited to the CYP46A1 promoter.
    Milagre I; Nunes MJ; Castro-Caldas M; Moutinho M; Gama MJ; Rodrigues E
    J Neurochem; 2012 Jan; 120(2):220-9. PubMed ID: 22060190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of oral turinabol by the human brain cholesterol 24-hydroxylase CYP46A1.
    Putkaradze N; Hartz P; Hutter MC; Zapp J; Thevis M; Bernhardt R
    J Steroid Biochem Mol Biol; 2021 Sep; 212():105927. PubMed ID: 34089835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Acetylcholine Levels and Other Brain Effects in 5XFAD Mice after Treatment with 8,14-Dihydroxy Metabolite of Efavirenz.
    Mast N; Li Y; Pikuleva IA
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation and metabolism of oxysterols and cholestenoic acids found in the mouse circulation: Lessons learnt from deuterium-enrichment experiments and the CYP46A1 transgenic mouse.
    Crick PJ; Yutuc E; Abdel-Khalik J; Saeed A; Betsholtz C; Genove G; Björkhem I; Wang Y; Griffiths WJ
    J Steroid Biochem Mol Biol; 2019 Dec; 195():105475. PubMed ID: 31541728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.